These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


594 related items for PubMed ID: 11079505

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F, Young S, Wilke F, Apostolova I, Arlt S, Jahn H, Thiele F, Buchert R.
    Neuroimage; 2010 Apr 15; 50(3):994-1003. PubMed ID: 20053378
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. FDG PET and differential diagnosis of dementia.
    Herholz K.
    Alzheimer Dis Assoc Disord; 1995 Apr 15; 9(1):6-16. PubMed ID: 7605624
    [Abstract] [Full Text] [Related]

  • 25. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M.
    J Nucl Med; 2001 Apr 15; 42(4):548-57. PubMed ID: 11337540
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C, Chiaravalloti A, Sancesario G, Stefani A, Sancesario GM, Mercuri NB, Schillaci O, Pierantozzi M.
    Eur J Nucl Med Mol Imaging; 2016 Oct 15; 43(11):2040-9. PubMed ID: 27221635
    [Abstract] [Full Text] [Related]

  • 28. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
    McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, Snowden JS, Varma AR.
    J Neurol Neurosurg Psychiatry; 2007 Apr 15; 78(4):350-5. PubMed ID: 17158559
    [Abstract] [Full Text] [Related]

  • 29. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Ye BS, Lee S, Yoo H, Chung SJ, Lee YH, Choi Y, Lee PH, Sohn YH, Yun M.
    Neurobiol Aging; 2020 Mar 15; 87():11-17. PubMed ID: 31791660
    [Abstract] [Full Text] [Related]

  • 30. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
    Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.
    Alzheimers Dement; 2015 Oct 15; 11(10):1191-201. PubMed ID: 25646957
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Positron emission tomography imaging in dementia.
    Herholz K, Carter SF, Jones M.
    Br J Radiol; 2007 Dec 15; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [Abstract] [Full Text] [Related]

  • 33. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
    Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SCJ, van Berckel BNM, Ossenkoppele R, Barkhof F, Larsson EM.
    Eur Radiol; 2017 Oct 15; 27(10):4237-4246. PubMed ID: 28374078
    [Abstract] [Full Text] [Related]

  • 34. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG, Wenzel F, Gartenschläger M, Thiele F, Young S, Reuss S, Schreckenberger M.
    Biomed Eng Online; 2015 Aug 18; 14():79. PubMed ID: 26281849
    [Abstract] [Full Text] [Related]

  • 35. Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease.
    McMurtray AM, Licht E, Yeo T, Krisztal E, Saul RE, Mendez MF.
    Eur Neurol; 2008 Aug 18; 59(1-2):31-7. PubMed ID: 17917455
    [Abstract] [Full Text] [Related]

  • 36. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb 18; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 37. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug 18; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 38. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC.
    J Alzheimers Dis; 2015 Aug 18; 43(4):1343-53. PubMed ID: 25147107
    [Abstract] [Full Text] [Related]

  • 39. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
    Krishnan K, Machulda MM, Whitwell JL, Butts AM, Duffy JR, Strand EA, Senjem ML, Spychalla AJ, Jack CR, Lowe VJ, Josephs KA.
    J Alzheimers Dis; 2017 Aug 18; 55(3):1019-1029. PubMed ID: 27802232
    [Abstract] [Full Text] [Related]

  • 40. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E, Franck G.
    Arch Gerontol Geriatr Suppl; 1989 Aug 18; 1():241-7. PubMed ID: 2787995
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 30.